Skip to main content
Cipla Ltd. logo

Cipla Ltd. — Investor Relations & Filings

Ticker · CIPLA ISIN · INE059A01026 LEI · 335800KMJJYEDDK82Q34 BSE.NS Manufacturing
Filings indexed 2,616 across all filing types
Latest filing 2020-02-20 Regulatory Filings
Country IN India
Listing BSE.NS CIPLA

About Cipla Ltd.

https://www.cipla.com/

Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.

Recent filings

Filing Released Lang Actions
In terms of the Company's Code of Conduct for Prevention of Insider Trading, the 'Trading Window' for dealing in the securities of the Company has been closed with immediate effect upto ....
Regulatory Filings Classification · 95% confidence The document is a notice from Cipla Ltd. addressed to stock exchanges regarding a scheduled Board of Directors meeting to consider and approve the payment of an interim dividend for the financial year 2019-20. It includes details about the record date for the interim dividend and mentions the closure of the trading window for insider trading prevention. The document is short (2529 characters) and serves as an announcement of an upcoming board meeting and dividend payment, not a full financial report or detailed dividend report. It does not contain actual financial statements or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement related to board decisions and dividend payment, but not a formal dividend notice or financial report itself.
2020-02-20 English
Board Meeting — Dividend
Notice of Dividend Amount Classification · 95% confidence The document is a notice from Cipla Ltd. addressed to stock exchanges regarding a scheduled Board of Directors meeting to consider and approve the payment of an interim dividend for the financial year 2019-20. It includes details about the record date for the interim dividend and mentions the closure of the trading window for insider trading prevention. The document is short (2529 characters) and serves as an announcement of a board meeting and dividend-related information rather than a full financial report or detailed dividend declaration. It does not contain actual financial statements or comprehensive financial data. Therefore, it is best classified as a Notice of Dividend Amount (DIV) since it announces dividend payment details and related dates.
2020-02-20 English
Record date for the purpose of payment of Interim Dividend would be as 20th March 2020, subject to the approval of the Board of Directors.
Regulatory Filings Classification · 95% confidence The document is a notice from Cipla Ltd. addressed to stock exchanges regarding a scheduled Board of Directors meeting to consider and approve the payment of an interim dividend for the financial year 2019-20. It includes details about the record date for the interim dividend and mentions the closure of the trading window for insider trading prevention. The document is short (2529 characters) and serves as an announcement of an upcoming board meeting and dividend payment, not a full financial report or detailed dividend report. It does not contain actual financial statements or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement related to board decisions and dividend payment, but not a formal dividend notice or financial report itself.
2020-02-20 English
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/03/2020 ,inter alia, to consider and approve payment of Interim Dividend for the ....
Notice of Dividend Amount Classification · 95% confidence The document is a notice from Cipla Ltd. addressed to stock exchanges regarding a scheduled Board of Directors meeting to consider and approve the payment of an interim dividend for the financial year 2019-20. It includes details about the record date for the interim dividend and mentions the closure of the trading window for insider trading prevention. The document is short (2529 characters) and primarily serves as an announcement of an upcoming board meeting and dividend payment, not a full financial report or detailed dividend declaration. It does not contain actual financial statements or detailed financial analysis. Therefore, it is best classified as a Notice of Dividend Amount (DIV), as it announces dividend payment details and related dates.
2020-02-20 English
Please find enclosed schedule of Institutional Investors/ Analysts meetings.
Fund Information / Factsheet Classification · 90% confidence The document is very short (333 characters) and contains a table listing dates, fund/investor names, venues, and types of meetings. There is no financial data, no detailed report content, no regulatory references, or any indication of a formal report. The content resembles a brief summary or factsheet about investor meetings or fund information. Given the brevity and nature of the content, it fits best as a Fund Information / Factsheet (FS).
2020-02-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Fund Information / Factsheet Classification · 90% confidence The document is very short (333 characters) and contains a table listing dates, fund/investor names, venues, and types of meetings. There is no financial data, no detailed report content, no regulatory references, or any indication of a formal report. The content resembles a brief summary or factsheet about investor meetings or fund information. Given the brevity and nature of the content, it fits best as a Fund Information / Factsheet (FS).
2020-02-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.